Moderna (NASDAQ: MRNA) was one of the hottest stocks to own during the rollout of COVID-19 vaccines a few years ago. These days, however, the hype has cooled off significantly. The company is facing big questions about its future growth, and there isn't a whole lot of bullishness surrounding the stock anymore. The stock dropped nearly 45% in 2023.

Moderna investors might be looking back and pondering how things have gone. Let's take a look at how much an investor would have today if they invested $10,000 into the stock before the pandemic.

At the end of 2019, Moderna was a high-risk business to invest in, having accumulated a deficit of $1.5 billion since its inception in 2009.

Continue reading

Source Fool.com